Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Matthew Perrone
Matthew Perrone, AP Health Writer
Page 6 of 7
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By
Matthew Perrone
and
The Associated Press
Health
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By
Matthew Perrone
and
The Associated Press
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
FDA will not make a decision on Merck’s COVID antiviral pill until December
By
Matthew Perrone
and
The Associated Press
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By
Matthew Perrone
and
The Associated Press
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By
Matthew Perrone
and
The Associated Press
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By
Matthew Perrone
,
Lauran Neergaard
, and others